AR049846A1 - Preparaciones farmaceuticas de derivados de la piperazina - Google Patents

Preparaciones farmaceuticas de derivados de la piperazina

Info

Publication number: AR049846A1
Authority: AR; Argentina
Prior art keywords: preservative; pharmaceutical preparations; piperazine derivatives; preservatives; less
Prior art date: 2004-07-14

Application number

ARP050102897A

Other languages

English (en)

Spanish (es)

Inventor

Domenico Fanara

Jean Scouvart

Claire Poulain

Michel Deleers

Original Assignee

Ucb Farchim Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-07-14

Filing date

2005-07-13

Publication date

2006-09-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34925743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR049846(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-07-13 Application filed by Ucb Farchim Sa filed Critical Ucb Farchim Sa

2006-09-06 Publication of AR049846A1 publication Critical patent/AR049846A1/es

Links

239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical class C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title 1
229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title 1
239000003755 preservative agent Substances 0.000 abstract 4
230000002335 preservative effect Effects 0.000 abstract 3
FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical class OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 abstract 2
239000007788 liquid Substances 0.000 abstract 2
ZKLPARSLTMPFCP-OAQYLSRUSA-N 2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]acetic acid Chemical compound C1CN(CCOCC(=O)O)CCN1[C@@H](C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-OAQYLSRUSA-N 0.000 abstract 1
BAWMMJAUVBLLEE-UHFFFAOYSA-N 2-[2-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]ethoxy]acetic acid Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 BAWMMJAUVBLLEE-UHFFFAOYSA-N 0.000 abstract 1
ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
229960001803 cetirizine Drugs 0.000 abstract 1
150000008640 diphenylmethylpiperazines Chemical group 0.000 abstract 1
229950003420 efletirizine Drugs 0.000 abstract 1
229960001508 levocetirizine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Otolaryngology (AREA)
Ophthalmology & Optometry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Immunology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)

ARP050102897A 2004-07-14 2005-07-13 Preparaciones farmaceuticas de derivados de la piperazina AR049846A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP04016519		2004-07-14

Publications (1)

Publication Number	Publication Date
AR049846A1 true AR049846A1 (es)	2006-09-06

Family

ID=34925743

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ARP050102897A AR049846A1 (es)	2004-07-14	2005-07-13	Preparaciones farmaceuticas de derivados de la piperazina

Country Status (25)

Country	Link
US (1)	US8633194B2 (de)
EP (1)	EP1768649B1 (de)
JP (1)	JP4902875B2 (de)
KR (1)	KR101185612B1 (de)
CN (1)	CN100508981C (de)
AR (1)	AR049846A1 (de)
AT (1)	ATE443512T1 (de)
AU (1)	AU2005261953B2 (de)
BR (1)	BRPI0513257C1 (de)
CA (1)	CA2573662A1 (de)
CY (1)	CY1109670T1 (de)
DE (1)	DE602005016802D1 (de)
EA (1)	EA012463B1 (de)
ES (1)	ES2332462T3 (de)
IL (1)	IL180010A0 (de)
MX (1)	MX2007000230A (de)
MY (1)	MY149403A (de)
NO (1)	NO337768B1 (de)
NZ (1)	NZ552182A (de)
PE (1)	PE20060484A1 (de)
PL (1)	PL1768649T3 (de)
PT (1)	PT1768649E (de)
TW (1)	TWI304339B (de)
WO (1)	WO2006005507A2 (de)
ZA (1)	ZA200700939B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2755679C (en)	2009-03-17	2017-09-12	Aciex Therapeutics, Inc.	Ophthalmic formulations of cetirizine and methods of use
US8569273B2 (en)	2009-03-17	2013-10-29	Aciex Therapeutics, Inc.	Ophthalmic formulations of cetirizine and methods of use
TWI503122B (zh) *	2012-02-15	2015-10-11	Taiho Pharmaceutical Co Ltd	Oral administration of pharmaceutical compositions
KR102155836B1 (ko)	2013-02-22	2020-09-14	삼성전자주식회사	터치 스크린 상에서 객체 디스플레이를 제어하는 휴대 단말 및 방법
WO2018147409A1 (ja) *	2017-02-13	2018-08-16	日東メディック株式会社	水性点眼点鼻用組成物
CN113712907A (zh) *	2020-05-25	2021-11-30	南京帝昌医药科技有限公司	一种盐酸左西替利嗪滴眼液组合物及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4255358A (en) *	1978-03-13	1981-03-10	The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland	Process for the production of hexanitrostilbene
FI75816C (fi)	1981-02-06	1988-08-08	Ucb Sa	Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
NZ215069A (en)	1985-03-01	1988-06-30	Reckitt & Colmann Prod Ltd	Pharmaceutical composition with histamine h 2 -receptor antagonist
US4728509A (en)	1985-08-19	1988-03-01	Takeda Chemical Industries, Ltd.	Aqueous liquid preparation
JP3278192B2 (ja)	1992-04-03	2002-04-30	ロート製薬株式会社	徐放性液剤
TW401300B (en)	1992-12-25	2000-08-11	Senju Pharma Co	Antiallergic composition for ophthalmic or nasal use
US5504113A (en)	1994-03-02	1996-04-02	Allergan, Inc.	Enhancement of benzalkonium chloride preservative activity in formulations containing an incompatible drug
WO1996011003A1 (en)	1994-10-10	1996-04-18	Novartis Ag	Ophthalmic and aural compositions containing diclofenac potassium
TW536403B (en)	1997-03-24	2003-06-11	Glaxo Group Ltd	An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
US6432961B1 (en)	1998-08-18	2002-08-13	Ucb S.A.	Method for preventing the onset of asthma
AUPQ419099A0 (en)	1999-11-23	1999-12-16	Ko, Thomas Sai Ying	Novel compositions and methods
DE10007203A1 (de)	2000-02-17	2001-08-23	Asta Medica Ag	Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
US6258814B1 (en)	2000-10-13	2001-07-10	Schering Corporation	Method of using cetirizine and pharmaceutical compositions containing the same for inducing sleep
UA80393C2 (uk) *	2000-12-07	2007-09-25	Алтана Фарма Аг	Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
AU2002221854A1 (en)	2000-12-15	2002-06-24	U C B, S.A.	Use of cetirizine or efletirizine for preventing urticaria
US6869618B2 (en)	2001-04-10	2005-03-22	Kiel Laboratories, Inc.	Process for preparing tannate liquid and semi-solid dosage forms
MXPA04012393A (es)	2002-06-12	2005-06-17	Chemocentryx	Derivados de piperazina 1-aril-4-substituidos para utilizar como antagonistas ccr1 para tratamiento de inflamacion y desordenes inmunes.
AU2003251152A1 (en)	2002-07-03	2004-01-23	Shannon Biotechnology Ltd	Pharmaceutical formulations for preparing drink products
EP1569650B1 (de)	2002-12-03	2008-05-28	Ucb Farchim S.A.	Verwendung von levocetirizin zur behandlung von persistierender allergischer rhinitis
US20050255154A1 (en)	2004-05-11	2005-11-17	Lena Pereswetoff-Morath	Method and composition for treating rhinitis
US20090137645A1 (en)	2007-10-31	2009-05-28	Midlothian Laboratories, Llc	Shelf-Stable Famotidine Granulates for Oral Suspensions

2005
- 2005-07-04 PE PE2005000777A patent/PE20060484A1/es not_active Application Discontinuation
- 2005-07-06 US US10/599,451 patent/US8633194B2/en active Active
- 2005-07-06 TW TW094122831A patent/TWI304339B/zh not_active IP Right Cessation
- 2005-07-07 AU AU2005261953A patent/AU2005261953B2/en not_active Expired
- 2005-07-07 MY MYPI20053111A patent/MY149403A/en unknown
- 2005-07-07 CN CNB2005800234732A patent/CN100508981C/zh not_active Ceased
- 2005-07-07 PT PT05758582T patent/PT1768649E/pt unknown
- 2005-07-07 WO PCT/EP2005/007340 patent/WO2006005507A2/en not_active Ceased
- 2005-07-07 EA EA200700067A patent/EA012463B1/ru not_active IP Right Cessation
- 2005-07-07 JP JP2007520716A patent/JP4902875B2/ja not_active Expired - Lifetime
- 2005-07-07 EP EP05758582A patent/EP1768649B1/de not_active Revoked
- 2005-07-07 ZA ZA200700939A patent/ZA200700939B/xx unknown
- 2005-07-07 AT AT05758582T patent/ATE443512T1/de active
- 2005-07-07 BR BRPI0513257A patent/BRPI0513257C1/pt active IP Right Grant
- 2005-07-07 KR KR1020077003545A patent/KR101185612B1/ko not_active Expired - Lifetime
- 2005-07-07 CA CA002573662A patent/CA2573662A1/en not_active Abandoned
- 2005-07-07 DE DE602005016802T patent/DE602005016802D1/de not_active Expired - Lifetime
- 2005-07-07 NZ NZ552182A patent/NZ552182A/en not_active IP Right Cessation
- 2005-07-07 MX MX2007000230A patent/MX2007000230A/es active IP Right Grant
- 2005-07-07 PL PL05758582T patent/PL1768649T3/pl unknown
- 2005-07-07 ES ES05758582T patent/ES2332462T3/es not_active Expired - Lifetime
- 2005-07-13 AR ARP050102897A patent/AR049846A1/es not_active Application Discontinuation
2006
- 2006-12-12 IL IL180010A patent/IL180010A0/en unknown
2007
- 2007-02-13 NO NO20070832A patent/NO337768B1/no unknown
2009
- 2009-11-25 CY CY20091101233T patent/CY1109670T1/el unknown

Also Published As

Publication number	Publication date
BRPI0513257C1 (pt)	2021-05-25
EP1768649B1 (de)	2009-09-23
TWI304339B (en)	2008-12-21
DE602005016802D1 (de)	2009-11-05
WO2006005507A3 (en)	2006-04-27
MX2007000230A (es)	2007-03-30
NO20070832L (no)	2007-02-13
US8633194B2 (en)	2014-01-21
CN1984641A (zh)	2007-06-20
AU2005261953A1 (en)	2006-01-19
ATE443512T1 (de)	2009-10-15
BRPI0513257B1 (pt)	2018-05-29
MY149403A (en)	2013-08-30
CN100508981C (zh)	2009-07-08
WO2006005507A8 (en)	2006-12-07
HK1103958A1 (zh)	2008-01-04
PE20060484A1 (es)	2006-07-06
CY1109670T1 (el)	2014-08-13
KR101185612B1 (ko)	2012-09-24
AU2005261953B2 (en)	2010-06-03
TW200605892A (en)	2006-02-16
KR20070043841A (ko)	2007-04-25
PT1768649E (pt)	2009-11-13
PL1768649T3 (pl)	2010-02-26
EA200700067A1 (ru)	2007-08-31
CA2573662A1 (en)	2006-01-19
JP4902875B2 (ja)	2012-03-21
NZ552182A (en)	2010-07-30
WO2006005507A2 (en)	2006-01-19
NO337768B1 (no)	2016-06-20
ZA200700939B (en)	2008-08-27
IL180010A0 (en)	2007-05-15
JP2008505949A (ja)	2008-02-28
EP1768649A2 (de)	2007-04-04
ES2332462T3 (es)	2010-02-05
BRPI0513257A (pt)	2008-04-29
EA012463B1 (ru)	2009-10-30
US20070275974A1 (en)	2007-11-29

Legal Events

Date	Code	Title	Description
2014-12-03	FA	Abandonment or withdrawal

Publication	Publication Date	Title
ES2169087T3 (es)	2002-07-01	Formulaciones orales de un antifungico.
EP1243524A3 (de)	2004-04-07	Pharmazeutisches Kit fÜr sauerstoffempfindliche Medikamente
PE20050438A1 (es)	2005-06-14	Formulas farmaceuticas, metodos y regimenes de dosificacion para el tratamiento y la prevencion de sindromes coronarios agudos
DE60312523D1 (de)	2007-04-26	Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit
BRPI0415121A (pt)	2006-11-28	material particulado, forma de dosagem sólida, método para fabricar a mesma, e, uso de um material particulado ou de uma forma de dosagem sólida
UA102478C2 (en)	2013-07-10	Capsule composition
EA200601253A1 (ru)	2006-12-29	Преимущественно линейная шипучая лекарственная форма фентанила для перорального применения и способы введения
NO20080220L (no)	2008-04-21	Formuleringer med hoy medikament belastning og doseringsformer
WO2005110398A3 (en)	2006-05-04	Pharmaceutical solution formulations containing 17-aag
AR034370A1 (es)	2004-02-18	Una preparacion farmaceutica acuosa de cilostazol para uso parenteral
EA201100430A1 (ru)	2011-10-31	Стабильная комбинированная фармацевтическая композиция
BRPI0311189B8 (pt)	2021-05-25	composições farmacêuticas contendo polimorfo a de flibanserin, bem como seu uso
IT1263840B (it)	1996-09-04	Formulazioni orali di ubidecarenone in forma di capsule
EA200601901A1 (ru)	2007-04-27	Композиции, содержащие иммуномодулирующие соединения для лечения и управления течением миелодиспластических синдромов и способы с их использованием
ECSP044979A (es)	2004-04-28	Uso de bibn4096 en combinación con otros fármacos antimigrañosos para el tratamiento de migraña
EA200401298A1 (ru)	2005-02-24	Жидкие фармацевтические композиции, содержащие низкую дозу энтекавира, и их применение
PT1414467E (pt)	2006-09-29	Tratamento topico da mastalgia
MX2012010935A (es)	2012-12-10	Formulacion acuosa estable mejorada de (e)-4-carboxiestiril-4-clor obencil sulfona.
NO20070832L (no)	2007-02-13	Farmasoytiske preparat av piperazinderivater.
SE0302924D0 (sv)	2003-11-05	Pharmaceutical composition having a cationic excipient
AR042598A1 (es)	2005-06-29	Composiciones de acetaminofeno
ES2197781A1 (es)	2004-01-01	Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.
BRPI0511387A (pt)	2007-12-04	composição e seu uso
EA200601015A1 (ru)	2006-10-27	Пероральные композиции дезоксипеганина и их применение
BR0214487A (pt)	2004-10-19	Composição farmacêutica que compreende uma combinação de metformina e um ácido 4-oxobutanóico, e o uso da mesma para o tratamento de diabetes